Last month over 80 researchers from across the globe joined the Ineos Oxford Institute (IOI) to mark the second phase of two studies, BALANCE (Burden of AMR and treatment failure in low-, middle- and high-income countries) and BARNARDS (Burden of Antibiotic Resistance in Neonates from Developing Societies).
Both studies explore the burden of antimicrobial resistance at hospitals around the world. BARNARDS focuses on hospital sites in low- and middle-income countries such as Sierra Leone, Nigeria and Ethiopia, whereas BALANCE analyses data collected from low-, middle- and high-income countries such as Italy, Pakistan, and Poland.
This workshop was incredibly important, as we were able to gain feedback from clinicians, site leads and microbiologists with local knowledge and have discussions as a group before starting the project at clinical sites. It was great for everyone to meet other collaborators within the network and build connections. We look forward to starting this project and working with the teams on the ground, and I am excited to see the outputs and what we can achieve together.
The key to success in international research of this scale is an open line of communication among the stakeholders within the network and the consistency of research progress across the sites. The kick-off meeting provided an opportunity to build a strong dynamic research team and to solidify our motto of working together for public interest.